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Abstract 
We present the ongoing studies aiming at providing a real-time control of the dose distribution during ion 
therapy. These studies are undertaken in the frame of the National and Rhône-Alpes Regional Research 
Programs for Hadontherapy. We aim at implementing combined modalities for real-time quality control of the 
deposited dose for future therapy centers. Several modalities are under development within this research 
program. Improvements on Positron Emission Tomography (PET) can be obtained by means of Time of Flight, 
using fast scintillators or resistive plate chambers, with dedicated readout and electronics. The in-bream 
prompt gamma imaging looks very promising in view of recent preliminary results, provided Time of Flight is 
used to discriminate gamma from neutrons and scattered particles. A collimated detection setup or a Compton 
camera is envisaged. Prompt emission of light charged particles like protons is also discussed. 
 
 
Introduction 
  The main distinctive characteristic of ion-therapy, as compared to conventional radiotherapy, is the highly 
non-uniform profile of dose deposition inside the irradiated body. The dose increases gradually along the ion 
path to reach a steep maximum at the Bragg peak. Beyond this point, the longitudinal dose drops down quite 
abruptly, since only a small flux of secondary particles contribute to it. The lateral dose distribution is also 
quite narrow. Indeed, the transverse dispersion comes mostly from multiple scattering of the charged 
projectiles before stopping.  
  Therefore, in vivo 3D-imaging of the dose is of utmost importance for quality control during patient 
treatment, and drives a diversified R&D program which includes a variety of techniques. The uncertainty on 
the location of the Bragg peak in the patient may be large, as much as 1 cm in some cases, due to the 
stoichiometric calibration of the CT images used in treatment planning, as well as to possible morphologic 
changes occuring between CT and treatment and during the treatment itself, such as patient mispositioning 
tumour shrinkage, weight change and organ motion. Since no primary radiation emerges from the patient, in 
vivo imaging must be performed exploiting secondary radiations. To be useful, such radiation must emerge 
from the patient, i.e. to have a weak interaction probability, and be correlated to the primary beam dose 
distribution. This information on the electromagnetic energy deposition (the LET) can be extracted from 
hadronic interactions [1,2,3].  
  A significant effort has been already deployed to address these issues and several techniques have been 
proposed and tested. The present paper reviews the various developments underway on the on-line beam dose 
deposition imaging that are performed within the Rhône-Alpes Regional Program for Research in 
Hadrontherapy, with the motivation of providing new methods for quality control in future therapy centers like 
ETOILE in Lyon. These developments include improvement of in-beam Positron Emission Tomography 
(IBPET) by means of time of flight, in-beam imaging by prompt gamma-rays and secondary charged particles. 
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Positron Emission Tomography 
  So far the only operating control system available during ion therapy is PET, which is based on the 
observation of the radiation from radioisotopes formed in the nuclei fragmentation process, namely the 
annihilation of β+ particles into two photons [3,4,5,6,7]. The main β+ radioactive isotopes formed during 
proton or carbon irradiation are 11C, 15O and 10C, with respective half-lives of 20 min, 2 min and 20 s. The 
suitability of various light ion beams for PET imaging has been studied at GSI and HIMAC [8,9,10]. Although 
only the target nuclei undergo fragmentation during proton therapy, the absolute rate of β+ emission induced 
during a treatment is higher by a factor of 3-5 for proton than for carbon irradiation, where also projectile 
fragmentation occurs, due to the larger fluence of protons required to provide the same effective dose.  
  The relatively short radioisotope lifetimes cited above make IBPET very attractive. This is the solution that 
was promoted by Enghardt et al. [11] with the dual-head PET BASTEI (Beta Activity Measurements at the 
Therapy with Energetic Ions) that has been installed at the GSI pilot project and has demonstrated its ability to 
provide a control of neck and head irradiations with carbon ions. The IBPET was used at GSI until 2008, 
whereas most of PET devices used in ion-therapy centers are offline, which necessitates the transport of the 
patient immediately after the treatment. However, the relatively low induced activities [12] require the 
acquisition of PET data for about 10 minutes or more, which limits considerably the patient flow in routine 
clinical environment in the case of IBPET. In addition, the integration of an IBPET device into a treatment site 
has to be arranged as a limited angle scanner, in order to avoid interference with the patient positioning. This 
causes artefacts in the reconstructed β+ activity distributions which partly destroy the relationship between 
dose and activity. Moreover, over such a period of acquisition time, the metabolism causes a wash-out of the 
radioactive nuclei, which blurs the image of the implanted radioactive isotopes [13]. The low statistics 
problem could be circumvented by using radioactive 11C ion beams instead of stable ions which, in addition, 
provide additional therapeutic dose after implantation due to the projectile radioactivity [14]. Tomitani et al 
have studied the biologic lifetime, i.e. the metabolic wash-out, of the implanted radio-elements in clinical 
conditions with rabbits. They reported that more than 50% of the β+ activity is lost within 4 minutes or less, 
depending on the tissue irradiated [15]. 
  Improvements of IBPET involve mainly the use of TOF between the two detected gammas. Indeed, during 
heavy ion treatments, a considerable amount of activity is coming from outside the field of view of the IBPET 
camera. An accuracy below 200 ps FWHM would reduce considerably the region of interest to a size of the 
same order as the tumor volume, and therefore decrease the number of background events registered. An 
important issue of PET imaging is the computer procedure needed to reconstruct an image and extract 
information about the deposited dose [16,17]. A significant gain on the reconstruction time could be obtained 
by increasing the coincidence accuracy by means of TOF between the two detected photons. This increase in 
image processing speed arises from the possibility to calculate at once the point of positron annihilation as 
soon as the coordinates of the hit detectors and the TOF information are known. Such an algorithm needs to 
process one single iteration through the collected data, unlike standard iterative reconstruction algorithms. 
Thus this would also reduce limited solid angle artifacts and open the way to quantitative imaging. 
  Lanthanum halide (LaBr3) scintillating crystals can in principle reach such 10-11s time resolution. For the 
readout of the scintillating material, two alternatives could be explored: fast, position-sensitive 
photomultipliers having sub-ns rise times, or the recently developed solid state Silicon PhotoMultiplier (SiPM). 
The SiPMs operate in the Geiger mode due to the avalanche nature of their signal, and they have a fast 
response time with nominal resolution of 50 ps or better. Unlike photomultipliers, SiPMs are not sensitive to 
magnetic fields, which makes them candidates for use in a multimodal TOF-PET – MRI. But they have not 
been used in large systems to date. 
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Prompt gamma imaging 
Since the probability for prompt gamma emission is expected to be of the same order as that for 
fragmentation, gamma imaging may be regarded as a competitive technique to provide real-time information 
about the local dose [18,19,20] both for proton and carbon ion therapy. 
Prompt gamma-rays are emitted by excited fragments with sufficiently small decay times so that the largest 
part of the photons are emitted in flight, keeping somewhat the information on the nuclear fragmentation 
location.  
However, measuring prompt gamma during a therapy treatment is not straightforward, since a major source 
of background arises from the emission of other secondary species like neutrons and light fragments, and also 
from Compton scattering of photons emitted in all directions. In particular, neutrons have a high multiplicity 
and high scattering probability in surrounding materials, and they may not be correlated to the ion path. 
Therefore, various alternatives are offered to provide selective information about the prompt gamma emission 
profile.  
1. Collimated gamma-camera 
The first one consists in a selective collimation and shielding. This method was followed by Min et al [18] 
during proton irradiation of a water phantom target. Using a scanning system based on a thick lead and paraffin 
collimator, the authors could demonstrate that the gamma emission profile keeps correlated with the proton 
range in water up to projectile incident energy of 200 MeV. However, the limited solid angle imposed by the 
heavy and oversized collimation setup may prevent this method from being operated in a clinical environment. 
 
2. Time Of Flight-gamma camera with beam tagging  
  In order to improve the detection efficiency and the background rejection, our group proposed a prompt 
gamma detection method [19,21] which uses time of flight information to discriminate between photons and 
massive particles. Indeed, massive particles and scattered radiations in the surrounding materials are delayed 
before reaching the photon detector, as compared to direct photons. The concept was tested on a carbon ion 
beam at GANIL, taking advantage of the pulsed structure of the incident beam, 1 ns pulse each 80 ns. Figure 1 
shows a 2D-spectrum of the energy detected by a collimated scintillator as a function of TOF for a 13C ion 
Figure 1. Two-dimensional spectrum of the γ-equivalent energy deposited in the NaI(Tl) detector as a function 
of the time of flight. The collimated scintillator aims at a location at the middle of the ion path (detection angle 
θ=90°) for a 74 MeV/u carbon ion beam inside a PMMA target. The left rectangle corresponds to a selection of 
prompt γ-rays, and the right one to a neutron selection [21]. 
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beam energy of 74 MeV/u impinging a thick PMMA target. The detector was located at 90° from the beam 
axis, at a distance of 60 cm from the target, with a narrow collimation slit (2 mm). The detected prompt gamma 
photons appear as a vertical band at short TOF values (the small drift with energy is due to electronics 
artifacts). However they account for only a minor fraction of the detected particles, which are dominated by 
neutrons.  
  The feasibility of the method is shown in Figure 2 which gives the longitudinal profile of the measured rates 
corresponding to the selections of prompt gammas only and of neutrons, above a given energy threshold, 
corresponding to the selection cuts highlighted in Figure 1. A photography of the irradiated sample shows 
clearly the beam range by means of the visible damage in the target. The Bragg peak corresponds to the sharp 
defect accumulation at the end of the range. The photon profile is well correlated to the ion range, whereas that 
for neutrons steadily increases with depth. Further studies performed at higher beam energies at GSI confirm 
that the correlation between prompt gamma yields and dose profile is preserved for carbon ions with longer 
ranges (in this case, the TOF was triggered by a thin scintillator intercepting the low intensity beam). This 
makes the proposed method feasible for the typical energies of carbon ion therapy. 
  The absolute photon yields measured are encouraging in view of designing a real-time control device during 
therapy. Although the solid angle of the collimated detector was small in these experiments, one can 
extrapolate the observed yields in view of a more efficient detection device. By increasing the solid angle by 
two orders of magnitude or more – which is made possible by minimizing the passive shielding against 
neutrons - enough contrast between the irradiated and non-irradiated zones should be observed within a few 
Figure 2: Detection rates as a function of the longitudinal position z obtained for the two different selections on 
the time of flight TOF and the energy deposited E in the detector indicated in Figure 1: photon selection 
(squares) and neutron selection (circles) [19]. Bottom: picture of the irradiated PMMA target. 
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seconds exposure, thus allowing a real-time control during patient treatments. These feasibility studies are 
combined with GEANT 4 simulations which, in a first step, provide direct comparison with theoretical models, 
and, in a second step, will help for designing an optimized detection setup. 
  A 2D-transverse position information on the incoming ions is required to complete the longitudinal profile. 
The incident beam tagging, in both time and transverse position, requires the development of a fast 
position-sensitive detector, with a count rate capability of 108 ions/s and 1 ns time resolution. A prototype, 
consisting in a scintillating fibers hodoscope read out by flat-panel PMs, is under development at IPN Lyon. 
Since scintillating fibers are affected by radiation damage on the intense primary beam, an alternative 
technology under consideration consists in polycrystalline diamond detectors, produced by Chemical Vapor 
Deposition (CVD) [22,23,24]. Such detectors exhibit quite good radiation tolerance. Diamond detectors can be 
obtained with large area, 1 ns or less timing resolution, and with x and y segmentation in order to cope with the 
high count rate and provide position information in an event by event mode. 
Although 3D-data are recorded by this method, the limited statistics imposed by the collimation may restrict 
the quantitative imaging to 1D or 2D projections. Nevertheless, this represents a considerable breakthrough in 
the quality control for ion-therapy, since this information is not yet available. 
 
3. Compton camera  
A considerable improvement in the detection of prompt photons can be achieved with a Compton Camera. 
The system can be considered to function like a standard γ-camera where the performance-limiting absorbing 
collimator is replaced by an electronically-operating collimator. A gamma ray emitted undergoes a Compton 
scattering in a first (scatter) detector, and the scattered photon which interacts in a secondary (absorption) 
detector conveys information on the direction of the incoming gamma ray. Information on energy deposition 
and interaction position in these detectors confines the possible incoming path of the initial gamma ray to lie 
on a cone, whose apex is the interaction position in the scatter detector. Compton cameras are currently under 
development worldwide, for application in gamma astronomy, medical imaging or homeland security [25,26]. 
For the case of prompt gamma imaging, where the source is extended and the energy spectrum is broad, the 
position and energy resolutions of the scatter detector are the key issues. A stack of Si(Li) detectors is 
envisaged [27]. In parallel, a specific reconstruction strategy, based on a precise iterative and fast analytic 
reconstruction algorithm, is under development. 
  The Compton camera solution, with an efficiency increase of nearly two orders of magnitude compared to a 
collimated gamma-camera, is a much more ambitious and promising technology allowing online real 
3D-imaging of the dose. Beyond the R&D challenges, a successful development of such a device would 
represent a major breakthrough in ion therapy imaging [28]. 
  
 
Charged Particle Imaging 
The analysis of charged particles, created in the ion interaction and fragmentation processes, which emerge 
from the patient offer a potential complementary opportunity to determine the points of interaction of the 
primary beam. The principle, which resembles that of vertex identification in fixed target particle physics 
experiments, is to reconstruct the trajectories of the particles emerging form the interactions by a precise 
charged particle hodoscope and extrapolate them back to their production point. The intercept of the trajectory 
of individual particle with the line of flight of the incoming ion, has been proposed in the context of the 
CNAO-sponsored AQUA quality assurance program and should provide a determination of the point of 
interaction with a resolution of a few mm, limited by multiple scattering and the effect of secondary 
interactions. Further, the possibility to use multiple particle tracks produced at the same interaction points 
would open the way to a real vertex reconstruction, intrinsically able to give a three-dimensional measurement 
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of the point of interaction with accuracies of the order of 1 mm. A program of simulation validation using data 
for the secondary proton yield and energy spectra and of secondary proton tracking and vertexing is currently 
being carried out jointly by IPN Lyon and TERA. In a second phase, a demonstration of the 3D reconstruction 
capabilities of these methods on a carbon ion beam using a small scale charged particle tracker and calorimeter 
is envisaged. 
 
 
Conclusion 
A diversified research program on online dose monitoring during ion therapy is currently ongoing, supported 
by the Rhône Alpes Regional Program for Research in Hadrontherapy. The program is carried out in the 
perspective of providing advanced and combined solutions for the treatment quality insurance to the ETOILE 
ion therapy, which is expected to treat the first patients by late 2012. These studies are also supported by 
CNRS-GDR MI2B. They are part of the European project ENVISION proposed by the ENLIGHT++ research 
network in the frame of the FP7. 
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